drugset

drugset / Trial / NCT00489450

Phase I Study to Investigate the Alcohol Interaction of SK3530

NCT00489450 ↗

Phase 1 Completed 18 enrolled SK Chemicals Co., Ltd.

RandomizedCrossoverOpen-labelTreatment

Summary

This study was designed to investigate the alcohol effect of SK3530 on the pharmacokinetics (PKs) and safety.

Timeline

Start: 2007-03
Primary completion: —
Completion: 2007-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Mirodenafil	Small molecule	100 mg	—

Indications